(-)-表没食子儿茶素没食子酸酯置于phosphate Buffer体系中,化学反应 48.0H,以30 Mg的收率获得产物没食子儿茶素没食子酸酯 参考文献:Stability Of Tea Polyphenol (−)-Epigallocatechin-3-Gallate And Formation Of Dimers And Epimers Under Common Experimental Conditions 标题:Stability Of Tea Polyphenol (−)-Epigallocatechin-3-Gallate And Formation Of Dimers And Epimers Under Common Experimental Conditions 摘要:(-)-表没食子儿茶素-3-没食子酸酯(egcg)是茶中含量最丰富且具有生物活性的化合物.其在动物模型和体外实验中的疾病预防活性已得到广泛研究.然而,其在不同实验条件下的稳定性尚未被充分表征.本研究探讨了egcg在动物饮用水和细胞培养条件下的稳定性及其影响稳定性的因素.研究结果表明,自身氧化和异构化是导致egcg不稳定的两大主要反应.主要氧化产物egcg二聚体的结构已被鉴定.这些反应的速率受温度,Ph值,氧气分压,抗氧化剂水平,Egcg浓度以及茶叶中的其他成分影响.在未来的egcg研究中,应考虑其稳定性以避免可能的实验假象. DOI:10.1021/jf0519055
专利号:US-2009170928-A1 优先权日:2005-04-28 标题:Synthesis of oligo/poly(catechins) and methods of use
专利号:CN-119979591-A 优先权日:2025-01-06 标 题 :Method for regulating and controlling synthesis of cis-catechin of tea tree based on CsAHL gene and application
专利号:WO-2019076178-A1 优先权日:2017-10-18 标 题:Medical degradable polyurethane with adjustable degradation time and adjustable elongation at break 发明人:ZHANG WENFANG 权利人:COMSCAFFOLDS NANJING MEDICAL DEVICE CO LTD 摘要:The invention provides a medical degradable polyurethane with adjustable degradation time and adjustable elongation at break, a preparation method and application thereof, and can adjust the proportion of each component in the polyurethane synthesis process and select different chain extenders. Control the performance of PU in a wide range, such as PU degradation time, elongation at break, strength, lubricity and hydrophilicity, etc., can choose different properties of medical degradable polyurethane according to the needs of regenerative medicine and medical devices implanted in the body. .
专利号:US-5605929-A 优先权日:1992-05-27 标题:Methods and compositions for inhibiting 5α-reductase activity 发明人:LIAO SHUTSUNG; LIANG TEHMING 权利人:ARCH DEV CORP 摘要:Disclosed are a novel class of antiandrogenic compounds including saturated and unsaturated fatty acids, catechin gallates, their derivatives, and synthetic analogs, their method of synthesis, and their use in treating disorders associated with androgenic activities. Also disclosed is the use of known compounds not previously known for their antiandrogenic activity in treating disorders related to androgenic activities and cancers.
专利号:CN-115028699-A 优先权日:2022-06-15 标 题:Transcription factor CsHsf24 and application thereof in promoting synthesis and control of tea tree flavonoid
专利号:CN-115612114-A 优先权日:2021-07-14 标 题:Method and application of copolymer film and its enzymatic self-assembly synthesis